NLS Pharmaceutics
NLS Pharmaceutics is a Switzerland-based biopharmaceutical company that researches and develops therapeutics for the treatment of central nervous system disorders.
Business Model:
Revenue: $0
Employees: 2-10
Rankings
Industries / Tags:
Detailed NLS Pharmaceutics Information
Geographic Data
Address: Alter Postplatz 2
City: Stans
State: nidwalden
Zip: CH-6370
Country: CH
Financial Info
Stage:
post ipo equity
Raised Last:
$4M
Raised Total:$7M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
NLS Pharmaceutics is a Switzerland-based biopharmaceutical company that researches and develops therapeutics for the treatment of central nervous system disorders.
Contact Phone:
+14141618000
Contact Email:
NLS Pharmaceutics went public on 1/29/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
1/29/2021
Ticker Symbol:
NLSP
IPO Price:
$4.15/share
Amount Raised:
$20M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2021 | Post-IPO Equity | 1 | $2.5M |
Yorkville Advisors Yorkville Advisors |
10/2022 | Post-IPO Equity | $4M | 5/2017 | Series B | - | 12/2022 | Post-IPO Equity | 1 | $10M |
BVF Partners BVF Partners |
1/2021 | IPO | $20M |
|
10/2022 | Private Placement | $4M | 4/2022 | Post-IPO Equity | $4.4M | 5/2017 | Series B | - | 5/2017 | Series B | - | 5/2017 | Series B | - |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
